Germany’s Medical Nutrition market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around 3.4% during the forecast period.
According to the Global Health and Wellness Survey, in 2018, about 70% of individuals who were aged 65 years and over were diagnosed with a metabolic condition in Germany. Furthermore, in these disorders, nutrition therapy is a critical component of the management to prevent acute complications, such as metabolic decompensation, and/or to prevent long-term complications of the given disorder.
Dietary therapy is critical for normal growth and development, to prevent acute complications, and/or to prevent long-term complications of the given disorder. A failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for patients with inherited metabolic disorders is lifelong. The management of patients with many inborn errors of metabolism requires a multidisciplinary approach that combines both nutrition and medical management.
The major factors attributing to the growth of the market are the aging population, increased disease diagnosis, increasing prevalence of metabolic disorders, and high spending on healthcare.
The actual number of patients undergoing diagnosis of metabolic disorders has increased over the decade, hence, there is an increase in the number of patients diagnosed.